Literature DB >> 8439765

Changes in lactate dehydrogenase isoenzyme pattern in patients with tumors of the central nervous system.

M N Subhash1, B S Rao, S K Shankar.   

Abstract

Lactate dehydrogenase (LDH) isoenzymes were studied in biopsy samples obtained from 100 benign and malignant brain tumors. Diagnosis was confirmed by histopathology. It is observed that all tumors investigated had elevated LDH activity and showed a LDH isoenzyme pattern which is different from that of normal brain. A pronounced cathodal shift was seen in malignant tumors like medulloblastoma, grade 3-4 astrocytomas and neuroblastomas, whereas anodal pattern was seen in benign tumors like grade 1-2 astrocytomas and oligodendrogliomas. Some tumors like meningiomas showed a midzone pattern like increased LDH3. It was possible to differentiate certain tumors on the basis of LDH isoenzyme pattern like medulloblastomas into differentiated and undifferentiated; craniopharyngiomas into recurring and non-recurring ones. LDH1/LDH5 ratio was low (< 1.0) in malignant tumors and high (5.0-14.0) in benign tumors and it was useful in differentiating tumors according to the degree of malignancy and biological behavior. It is observed that both LDH isoenzyme pattern and LDH1/LDH5 ratio could be used as an adjuvant to histopathological grading of brain tumors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8439765     DOI: 10.1016/0197-0186(93)90004-o

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  7 in total

1.  Glucose metabolism heterogeneity in human and mouse malignant glioma cell lines.

Authors:  Corinne E Griguer; Claudia R Oliva; G Yancey Gillespie
Journal:  J Neurooncol       Date:  2005-09       Impact factor: 4.130

Review 2.  Neuronal-astrocyte metabolic interactions: understanding the transition into abnormal astrocytoma metabolism.

Authors:  Dennis A Turner; David Cory Adamson
Journal:  J Neuropathol Exp Neurol       Date:  2011-03       Impact factor: 3.685

3.  Hyperpolarized 13C magnetic resonance metabolic imaging: application to brain tumors.

Authors:  Ilwoo Park; Peder E Z Larson; Matthew L Zierhut; Simon Hu; Robert Bok; Tomoko Ozawa; John Kurhanewicz; Daniel B Vigneron; Scott R Vandenberg; C David James; Sarah J Nelson
Journal:  Neuro Oncol       Date:  2010-01-25       Impact factor: 12.300

4.  Mutation of mitochondria genome: trigger of somatic cell transforming to cancer cell.

Authors:  Du Jianping
Journal:  Int Arch Med       Date:  2010-02-05

Review 5.  A systematic approach to the diagnosis of suspected central nervous system lymphoma.

Authors:  Brian J Scott; Vanja C Douglas; Tarik Tihan; James L Rubenstein; S Andrew Josephson
Journal:  JAMA Neurol       Date:  2013-03-01       Impact factor: 18.302

Review 6.  Hyperpolarization MRI: Preclinical Models and Potential Applications in Neuroradiology.

Authors:  Vesselin Z Miloushev; Kayvan R Keshari; Andrei I Holodny
Journal:  Top Magn Reson Imaging       Date:  2016-02

Review 7.  Targeting Glutamine Addiction in Gliomas.

Authors:  Marta Obara-Michlewska; Monika Szeliga
Journal:  Cancers (Basel)       Date:  2020-01-29       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.